/HCA%20Healthcare%20Inc%20sign%20on%20building-by%20JHVEPhoto%20via%20Shutterstock.jpg)
HCA Healthcare has significantly outperformed the broader market this year, and Wall Street analysts are bullish about the stock’s prospects.
/Universal%20Health%20Services%2C%20Inc_%20logo%20on%20phone-by%20IgorGolovniov%20via%20Shutterstock.jpg)
Despite Universal Health Services’ outperformance relative to the broader market over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.
/Quest%20Diagnostics%2C%20Inc_%20logo%20on%20building-by%20Tada%20Images%20via%20Shutterstock.jpg)
As Quest Diagnostics underperformed relative to the S&P 500 Index over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.
/Humana%20Inc_%20logo%20on%20laptop-by%20monticello%20via%20Shutterstock.jpg)
Despite Humana underperforming the broader market over the past year, Wall Street analysts remain moderately bullish on the stock’s prospects.
/Henry%20Schein%20Inc_%20sign%20outside%20office-by%20JHVEPhoto%20via%20Shutterstock.jpg)
As Henry Schein underperformed the broader market over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.
/DaVita%20Inc%20sign%20on%20building-by%20photo-denver%20via%20Shutterstock.jpg)
DaVita has surpassed the broader market over the past year, and Wall Street analysts are cautious about the stock’s prospects.
/Cardinal%20Health%2C%20Inc_%20magnified-by%20Casimiro%20PT%20via%20Shutterstock.jpg)
Cardinal Health has underperformed the broader market over the past year, but Wall Street analysts are moderately bullish about the stock’s prospects.
DaVita is expected to release its fiscal second-quarter earnings next month, and analysts project a double-digit profit increase.
/Universal%20Health%20Services%2C%20Inc_%20magnified-%20by%20Casimiro%20PT%20via%20Shutterstock.jpg)
Universal Health Services is all set to announce its second-quarter results this month, and Wall Street analysts predict a solid double-digit earnings growth.
/Quest%20Diagnostics%2C%20Inc_%20inside%20office-by%20Kit%20Leong%20via%20Shutterstock.jpg)
As Quest Diagnostics gears up to unveil its second-quarter earnings results, Wall Street analysts remain cautiously optimistic about the stock’s prospects.